| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.66 | 0.02 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.29 | 0.02 |